Molecular Analysis Improves FH Prognosis & Risk Stratification
Physician's Weekly
JUNE 24, 2025
Adding genetic testing to clinical familial hypercholesterolemia screening improves risk assessment, prognosis and helps to guide targeted therapy. These individuals have total cholesterol counts exceeding 240 mg/dL, which increases their risk of heart disease. Through testing that screened for 11 genetic markers, 67.9%
Let's personalize your content